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INTRODUCTION
Cytotoxic T lymphocytes (CTL) and Natural killer (NK) cells play a central role in the defence against viruses and tumours 1 . CTL and NK cells perform their cytolytic function by specifically recognizing and eliminating infected and transformed cells in a process dependent on the polarized secretion of perforin and granzymes at the immunological synapse 1, 2 . In humans, the importance of this effector function is highlighted by an immunopathological condition observed in patients with inborn errors affecting lymphocyte cytotoxic function 2, 3 .
These disorders result in a life-threatening condition known as Hemophagocytic lymphohistiocytic syndrome (HLH), an immune dysregulation characterized by the loss of lymphocytes homeostasis and a severe hyperinflammation 3, 4 . HLH patients present with nonremitting fever, hepatosplenomegaly, hypercytokinemia, accumulation of activated CD8 T cells and organ infiltration by activated macrophages that phagocytose cellular elements and red-blood cells (i.e. hemophagocytosis) 4 . In humans, the onset of HLH is believed to be triggered mainly by viral infection, but HLH can also occur in the absence of any detectable pathogen 3, 5 .
Familial forms of HLH (FHL) are caused by mutations affecting the cytolytic effector protein perforin, or proteins involved in the molecular machinery required for the biogenesis and/or transport of perforin-containing vesicles to the immune synapse 2 . Thus, mutations in perforin (PRF1) are responsible for FHL type 2 (FHL2) 6 , UNC13-D for FHL3 7 , STX11 for FHL4 8 and STXBP2 for FHL5 9 . HLH can also be presented with hypopigmentation as in Gricelli syndrome type 2 (RAB27A) and Chediak-Higashi syndrome (LYST) [10] [11] [12] .
Our understanding of the immunopathological mechanisms responsible for HLH development has benefited from the availability of several murine models of HLH. Cytotoxic-deficient mice (such as Prf1, Rab27a, Unc13d, Stx11 and Lyst mice) develop a severe HLH-like syndrome after infection with lymphocytic choriomeningitis virus (LCMV) [13] [14] [15] [16] [17] [18] . In the absence of cytotoxic activity of CD8 T cells, an accumulation of the antigen-presenting cells that continuously activate CTL was reported in Prf1-/-mice 19 . The hyper-activated CTL secrete high levels of IFN-γ, which appears critical for the development of HLH-like symptoms 13, 20 .
MyD88 signalling is also thought to be important for HLH-like development, since in Unc13d
Myd88 double knock-out mice a reduction in CTL and macrophage activation has been observed 21 . The crucial role of CTL and IFN-γ for HLH-like development has been highlighted by experiments where depletion of CTL or blocking of IFN-γ, prevents and reduces HLH-like manifestations, respectively 13, 17, 20 . Despite the fact that injection of anti-NK1.1 depleting antibodies in Prf1-/-mice did not prevent development of HLH-like symptoms 13 , the contribution of NK cytotoxic activity to HLH immunopathogenesis has not been fully addressed. Recently, NK cells were shown to play an important immunoregulatory role by limiting hyper-activation of CTL in a mechanism dependent on perforin [22] [23] [24] . Whether or not a similar mechanism may participate in the pathogenesis of HLH is unknown.
In this study, we dissect the specific contribution of NK cell cytotoxic activity to HLH development. By generating murine models in which cytotoxic defects are restricted to CTL or NK cells, we show that both CTL and cytotoxic NK cells contribute to the development of HLH-like syndrome in mice after LCMV infection. Interestingly, our results show that the mechanism by which the cytotoxic function of CTL and NK cells prevents HLH-like manifestations differs. Whereas CTL cytotoxicity mainly acts on viral clearance, NK cytotoxic activity limits hyper-activation of CTL and tissue infiltration by activated macrophages. Thus, our data show that these cytotoxic lymphocytes subsets play nonredundant roles in immune homeostasis and the prevention of LCMV-induced immunopathology.
METHODS
Mice. Stx11 flox/flox , Stx11-/-, C57BL/6J wt and C57BL/6J-Prf1 tm1Sdz /J have been described previously 16 . Ncr1 greenCre mice were described previously 25 . C57BL/6J Rag2-/-Il2rg-/-CD45.2 and C57BL/6J Rag2-/-CD45.1 mice were kindly provided by Dr. Benedita Rocha (INEM, Paris). P14 CD45.1 mice were described previously 16 . P14 Prf1-/-CD45.1 mice were generated by breeding P14 CD45.1 mice with Prf1-/-CD45.2 mice. Mice were maintained in pathogen-free conditions and handled according to national and institutional guidelines.
Induction of HLH-like syndrome by LCMV infection. The WE strain of LCMV was
kindly provided by Professors Maries van de Broek and Rolf Zinkernagel (University of Zürich, Switzerland). Mice aged 8-14 weeks received an i.p. injection of 200 pfu. Blood counts were checked after infection using an automated cell counter (the MS 9-5 V, Melet Schloesing Laboratories). Serum levels of alanine and aspartate aminotransferase were determined using the VetTest ® Chemistry Analyzer (IDEXX Laboratories). The serum IFN-γ concentration was determined using an ELISA kit (eBioscience). The serum levels of other cytokines and chemokine were quantified by CBA kit (BD Bioscience).
LCMV viral load was assessed by quantitative PCR as described previously 16 . Briefly, cDNA was isolated from tissue samples and analyzed with primers for LCMV (forward: 5'-TCTCATCCCAACCATTTGCA-3' and reverse: 5'-GGGAAATTTGACAGCACAACAA-3') and β-actin (forward: 5'-CCAGCAGATGTGGATCAGCA-3' and reverse: 5'-CTTGCGGTGCACGATGG-3') using SYBR Green PCR Master Mix (Applied Biosystems).
In vitro CD8 + T and NK cell activation and degranulation assays. Spleen CD8 + T cells
were purified from the spleen and activated in vitro with a T cell activation/expansion kit (Miltenyi) in the presence of 50 U/ml of recombinant IL-2. After 5 days, T cell degranulation 6 was assayed by activating 4 x 10 5 cells with different concentrations of anti-CD3e (clone 500A2, eBioscience) in the presence of PE-coupled anti-CD107a (clone 1D4B, eBioscience) antibody. Degranulation capacity was assayed in CD8 + T cells and compared with nonactivated cells and the corresponding isotype control.
NK cells were purified from the spleen by negative selection (Miltenyi, NK isolation kit) and cultured in vitro in the presence of 50 ng/ml IL-15 for 7 days. NK degranulation was assessed following incubation with YAC-1 target cells.
In vivo T cell proliferation.
To measure T cell proliferation, 1 x 10 6 CFSE-labeled perforinsufficient or -deficient P14 CD45.1 CD8 T cells were transferred i.v. into mice carrying perforin-sufficient or perforin-deficient T cells mice, respectively at day -1. At day 0, recipient mice were infected with 200 pfu of LCMV i.v. Three days later, CFSE dilution was assessed by FACS analysis (gated on CD8 + CD45.1 + cells).
NK cell depletion.
Starting at day -2, anti-NK1.1 depleting antibody (clone PK136) was administrated by i.p. injection (50 ug) every 3 days in order to deplete NK1.1 expressing cells. Under these conditions, more than 90% of NK deletion in blood was achieved (data not shown). At day 0 mice were infected with a single dose of 200 p.f.u. of LCMV and HLH-like syndrome was evaluated as previously described 16 .
Bone-marrow reconstitution. For bone marrow transfer, 3 weeks old Rag2-/-Il2rg-/-CD45.2 and Rag2-/-CD45.1 mice were injected i.v. with 2 x 10 7 marrow cells from control or Prf1-/-mice. Immune reconstitution was monitored by FACS analysis and by measuring total lymphocytes blood counts using an automated cell counter (the MS 9-5 V, Melet Schloesing Laboratories). After at least 8 weeks of marrow transfer and complete immune reconstitution, mice were challenged with 200 p.f.u of LCMV to induce HLH-like syndrome as described above.
Statistical analysis. Data were analyzed with GraphPad Prism 6 software. Survival curves were analyzed using the log-rank test. All other analyses were performed using t-tests or oneway ANOVA with posttest. Differences were considered to be statistically significant when p < 0.05 (indicated as *p<0.05, **p<0.01 and ***p<0.001).
RESULTS

Natural killer cell cytotoxic activity reduces HLH-like manifestations in mice
It has been extensively documented that cytotoxicity-deficient CD8 T cells are the main driving force for immunopathogenesis in mouse models of HLH-like disease 13, 17, 19, 26 . In contrast, the contribution of NK cells to HLH-like manifestations is less clear. Depletion of NK cells in Prf1-/-mice did not prevent HLH-like development, suggesting that NK cells were dispensable for the initiation of this syndrome 13 . To specifically determine the contribution of NK cells in the development of HLH-like disease, we utilized LCMV-infected perforin-deficient mice, as these mice develop a disease pathology that closely mimics human HLH. We generated chimeric mice by transferring bone marrow from control or Prf1-/-mice on the CD45.2 background into Rag2-/-Il2rg-/-CD45.2 (lacking both, T and NK populations) or Rag2-/-CD45.1 (lacking only T cells) mice. Following BM transfer, primary and secondary lymphoid organs were repopulated with mature T and NK cells (Supplementary Figure 1A) . When Rag2-/-Il2rg-/-mice were reconstituted with control or Prf1-/-BM as donor cells, both T and NK cells were CD45.2, i.e., cytotoxic proficient (T Prf1+ NK Prf1+ mice) or deficient (T Prf1-NK Prf1mice) respectively. In contrast, when Rag2-/-CD45.1 mice were reconstituted with Prf1-/-BM, T cells were cytotoxic deficient since they developed from donor cells (CD45.2), whereas NK cells were cytotoxic proficient since they were endogenously (CD45.1) derived (T Prf1-NK Prf1+ mice) (Supplementary Figure 1B) .
To determine the contribution of NK cytotoxic activity to HLH-like development, we infected T Prf1+ NK Prf1+ , T Prf1-NK Prf1and T Prf1-NK Prf1+ mice with a single dose of 200 p.f.u. of LCMV. As expected, upon LCMV injection, T Prf1+ NK Prf1+ mice survived the infection, whereas mice in which both T and NK cells were deficient in cytotoxic activity, succumbed before 28 days post-infection ( Figure 1A) . Besides the increased susceptibility to LCMV, T Prf1-NK Prf1mice presented a significant loss of body weight and a dramatic drop in body temperature compared with T Prf1+ NK Prf1+ mice ( Figure 1A) . Interestingly, the presence of cytotoxic NK cells in an otherwise perforin-deficient recipient (T Prf1-NK Prf1+ mice) could significantly prolong survival after infection ( Figure 1A ). T Prf1-NK Prf1+ mice presented with an intermediate phenotype in terms of body weight and body temperature. Compared to control mice, T Prf1-NK Prf1mice presented the typical biological features of HLH-like immunopathology, including leukopenia, decreased numbers of red-blood cells, haematocrit and platelets and lack of neutrophilia on day 14 post-infection ( Figure 1B-1D ). In contrast, T Prf1-NK Prf1+ mice displayed normal RBC and platelet counts on day 14 post-infection ( Figure 1C ), although blood leukocyte numbers were reduced compared to T Prf1+ NK Prf1+ mice ( Figure 1B, 1D ).
An HLH-like syndrome in T Prf1-NK Prf1mice was associated with splenomegaly and liverinfiltration by activated immune cells (Figure 2A , 2B). Interestingly, splenomegaly and liverinfiltration after LCMV infection was comparable between T Prf1+ NK Prf1+ and T Prf1-NK Prf1+ mice (Figure 2A, 2B ). MNC liver-infiltrate in T Prf1-NK Prf1mice was highly enriched in activated CD8 T cells, while percentage and absolute numbers of these cells were lower in T Prf1+ NK Prf1+ and T Prf1-NK Prf1+ mice ( Figure 2C ). Strikingly, similar absolute numbers of liver-infiltrating NK cells were detected in all three conditions, indicating that phenotypic differences between T Prf1-NK Prf1and T Prf1-NK Prf1+ mice were qualitative ( Figure 2C ). Tissue-infiltration of macrophages is one of the hallmarks of HLH, and macrophages are one of the most important effector populations in the later phases of HLH immunopathology. Interestingly, macrophage liver-infiltration on day 14 post-infection was significantly reduced in T Prf1+ NK Prf1+ and T Prf1-NK Prf1+ mice, as compared to fully cytotoxic-deficient mice ( Figure 2D ). Reduction of inflammatory macrophages (defined as CD64 + Ly6C + cells 27, 28 ) infiltration in T Prf1-NK Prf1+ mice was observed both in terms of percentage and absolute numbers compared to T Prf1-NK Prf1mice ( Figure 2D ). Interestingly, reduced numbers of inflammatory macrophages correlated with a reduction in levels of serum liver transaminases (ALAT and ASAT) in T Prf1+ NK Prf1+ and T Prf1-NK Prf1+ mice compared to mice that lacked all cytotoxic activity ( Figure 2E ). IFN-γ is known to be a critical factor in LCMV-induced HLH-like syndrome, since in vivo neutralization of IFN-γ can reduce HLH-like manifestations in mice 13, 20 . To determine whether or not the moderate HLH-like manifestations observed in T Prf1-NK Prf1+ mice correlated with reduced levels of IFN-γ secretion, we measured IFN-γ production on day 8 postinfection. As expected, T Prf1-NK Prf1mice had higher levels of IFN-γ compared to T Prf1+ NK Prf1+ mice ( Figure 2F ). Interestingly, T Prf1-NK Prf1+ mice displayed similar serum IFN-γ levels as T Prf1-NK Prf1mice ( Figure 2F ) suggesting that reduction of HLH-like manifestations in the presence of cytotoxic proficient NK cells was not mediated by a reduction in serum IFN-γ levels. HLHlike syndrome is characterized by production of high levels of inflammatory cytokines that contribute to the hyper inflammatory environment. Interestingly, serum levels of inflammatory cytokines and chemokines, including IL-6, CCL2, and CCL5, were similar in T Prf1-NK Prf1and T Prf-NK Prf+ mice ( Figure 2G ).
Overall, these data show that when cytotoxic potential in mice is strictly limited to NK cells, HLH-like disease manifestations triggered by LCMV infection are dramatically reduced compared to mice that globally lack cytotoxic activity.
Reduction of HLH-like manifestations in T -NK + mice is independent of viral load
Defective viral control and persistent LCMV infection are considered key factors in HLH-like pathogenesis. To address whether the reduction of HLH-like manifestations in mice carrying cytotoxic-proficient NK cells was accompanied by a more efficient viral clearance, we measured viral load in the liver 14 and 21 days upon infection in T Prf1+ NK Prf1+ , T Prf1-NK Prf1and T Prf1-NK Prf1+ mice. Cytotoxic proficient T Prf1+ NK Prf1+ mice were able to control LCMV replication and successfully cleared the virus (Figure 3 ). In contrast, cytotoxic-deficient T Prf1-NK Prf1mice were unable to control the virus and displayed a high LCMV load ( Figure 3 ).
Interestingly, T Prf1-NK Prf1+ mice were unable to control LCMV replication and showed similar viral titers as compared to mice that were completely deficient in cytotoxicity ( Figure 3) .
Similar results were observed in the spleen 14 days after LCMV infection (Supplemental Figure 2 ). Thus, these data show that the improvement of HLH-like manifestations associated with cytotoxic-proficient NK cells appears to be independent of viral replication control in vivo.
In vivo depletion of cytotoxic proficient Natural Killer cells restores HLH-like syndrome severity
In order to determine whether the improvement of HLH-like manifestations observed in T Prf1- Figure 2 ). Thus, these data show that the improvement of HLH-like manifestations observed in T Prf1-NK Prf1+ mice depend on the presence of endogenous cytotoxic proficient NK cells. In this setting, NK cytotoxic activity appears to be sufficient to partially prevent HLH-like development in mice.
Natural killer cells cytotoxic defect does not induce HLH-like syndrome in mice but causes leukocytosis
These results suggest that NK cytotoxic activity contributes to prevent HLH-like development by a mechanism independent of viral clearance. In order to determine whether defective NK cytotoxic activity was sufficient to induce HLH-like development upon viral infection, we studied a second mouse model in which a defect in cytotoxicity was restricted to NK cells. As mice harbouring a conditional perforin allele are not yet available, we created mice with a NK cell-specific ablation of Stx11, a protein that is required for release of perforin-containing cytotoxic granules 16, 17, 29 . We crossed loxP-flanked Stx11 mice 16 
Natural killer cells cytotoxic activity controls T cell response in vivo.
Taken together, the beneficial role of natural killer cell cytotoxic activity in alleviating HLHlike manifestations as observed in T Prf1-NK Prf1+ mice (Figure 1 ) and the differential immune response observed in LCMV-infected T + NK Stx11mice ( Figure 5 ) suggest that NK cytotoxic activity modulates CTL proliferation upon LCMV viral infection. To test this hypothesis, we assessed CD8 T cell proliferation in T Prf1-NK Prf1+ and T + NK Stx11mice and compared them with their respective controls. We adoptively transferred perforin-sufficient or -deficient CFSE labelled P14 TCR transgenic CD8 T cells into T Prf1+ NK Prf1+ , T Prf1-NK Prf1and T Prf1-NK Prf1+ mice which were subsequently infected with 200 p.f.u. LCMV. Three days after infection, CFSE dilution was analyzed as a measure of CTL proliferation. Although LCMV titers were similar in all conditions (data not shown), P14 CD8 T cells had a higher proliferative capacity in T Prf1-NK Prf1mice as compared to T Prf1+ NK Prf1+ mice ( Figure 6A ). In T Prf1-NK Prf1+ mice, P14 CD8 proliferation was similar to the level observed in T Prf1+ NK Prf1+ mice ( Figure 6A ). Accordingly, absolute numbers of P14 CD8 cells were significantly higher in the spleen of complete cytotoxic-deficient mice compared with control T Prf1+ NK Prf1+ mice ( Figure 6B ). Strikingly, the presence of NK cytotoxic proficient cells reduced absolute numbers of P14 CD8 T cells in the spleen to values similar to those seen in T Prf1+ NK Prf1+ mice ( Figure 6B ). Interestingly, during the course of the anti-LCMV response, activation of endogenous CD8 T cells was also reduced in T Prf1-NK Prf1+ mice compared with fully cytotoxic-deficient mice. The fraction of KLRG1 + Ly6C + among endogenous CD8 T cells was 2-fold increased in T Prf1-NK Prf1mice compared to T Prf1+ NK Prf1+ and T Prf1-NK Prf1+ mice ( Figure 6C ).
To determine the impact of defective NK cytotoxic activity on CTL activation, we adoptively transferred perforin-sufficient or -deficient P14 cells to control, Stx11-/-and T + NK Stx11mice and 3 days after LCMV infection, P14 cell proliferation was assessed. P14 cell proliferation was found significantly higher in fully cytotoxic deficient mice compared to control mice in terms of P14 cells, presenting a higher percentage of cells in proliferation and total number of P14 cells present in the spleen ( Figure 6D ). Notably, in T + NK Stx11mice P14 CD8 T cells proliferated significantly more compared to control mice, as a higher percentage of P14 cells presented increased number of division cycles ( Figure 6D ). The absolute counts of P14 cells per spleen were moderately increased in T + NK Stx11mice as compared to those measured in the spleen of control mice ( Figure 6E ). Altogether, these results show that NK cell cytotoxic activity controls activation of cytotoxic CD8 T cells, suggesting that in a cytotoxic deficient host, the loss of such a mechanism could contribute to the hyper activation of lymphocytes in the settings of LCMV infection, which is a hallmark of the immunopathological events responsible for HLH-like development.
DISCUSSION
In the current study, we dissected the specific roles for cytotoxic NK and T cells to HLH-like development, by targeting the cytotoxic defect to each of the two main cytotoxic lymphocyte populations. Firstly, we found that in mice, CD8 T cells with impaired cytotoxicity (perforin- Natural killer cells control the immune response by secreting cytokines, controlling antigen presentation and directly killing infected or tumour transformed cells 30 . There is growing evidence that NK cells control CD8 T cells response via a perforin-dependent mechanism by limiting CD4 help during early stages of CTL activation and differentiation and/or by direct killing of early-activated CTL 22, 23 . Several NK receptors have been shown to participate in this process, especially NKG2D and NKp46 23, 31 . Recently, it has been shown that during early stages of anti LMCV response, CTL can escape NK surveillance by increasing the expression of MHC-I inhibitory NK ligands and by decreasing the expression of activating NK receptor ligands in a type I IFN dependent process 31, 32 . In our study, by using either bone marrow reconstituted or conditional knock-out mice we show that i) the presence of NK cytotoxic proficient cells restrains accumulation of LCMV specific CD8 T cells and ii) that, defective NK cell cytotoxicity correlates with a higher proliferation rate of antigen-specific CTL.
Whether NK cells modulate CD8 T cell responses by direct or indirect NK-T cell recognition
and the specific receptors involved in this process is a matter of further investigations.
Our study demonstrates that NK cell cytotoxic activity is essential for preventing HLH-like development caused by LCMV infection in mice. We speculate that by doing so, NK cells can directly limit CTL hyper activation and/or function. Another possibility is that NK cells also interfere with the effector phase of HLH-like syndrome by targeting activated macrophages and limiting therefore tissue destruction. Importantly, the diminished immunopathology We and others have shown the principal role of IFN-γ in HLH-like development caused by LCMV 13, 20 . Strikingly, the beneficial effect of NK cytotoxic activity in reducing HLH-like pathology was not related to a decrease in IFN-γ serum levels in T Prf1-NK Prf1+ mice, as it would have been expected. However, IFN-γ levels were measured in the serum and this does not necessarily reflect the actual concentration in the tissue. The cellular source of IFN-γ in the tissues during HLH-like remains a question to be addressed. Furthermore, the sustained secretion of inflammatory cytokines observed in NK proficient mice, suggests that NK cytotoxicity rather interferes directly with effector cells that could be T cells and/or macrophages.
HLH is a heterogeneous syndrome that can present variations in the manifestations and symptoms observed in the patients 3 . Some of these variations can be attributed to the nature of the genetic cause, environmental factors, etc. Whether some of these variations can be attributed to residual cytotoxic activity in one of the two main lymphocyte populations might be an appealing possibility. The fact that residual NK cytotoxic activity can improve HLHlike manifestations puts forward alternative therapeutic options that include the stimulation of complement-dependent cytotoxic mechanisms to eliminate hyper activated CD8 T cells by the administration of Fc-fusion(s) proteins targeting the receptors/ligands involved in this cytotoxic process, as it has been proposed in an experimental tumour model 33 .
In this report we have highlighted a previously unappreciated role of NK cytotoxicity in immune homeostasis by dissecting the specific contribution of NK and CD8 T cells to HLH- 
